CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab

Authors:

Abstract
In addition to spontaneous release during migraine, CGRP can be released from trigeminal nerve endings by external stimuli. Application of capsaicin on the forehead releases CGRP via activation of the transient receptor potential cation channel subfamily V member 1 of the trigeminal nerve and thereby increases forehead dermal blood flow (DBF).2 Forearm application of capsaicin also increases DBF and this effect can be inhibited by erenumab, but the dose–response relationship in this model does not seem to be indicative for clinical responses.3
Funding Information
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Spinoza Award 2009 to MDF, VICI grant 09150181910040 to AMvdB)